IMARC Group's report titled "Pet Diabetes Care Market Report by Solution (Treatment, Glucose Monitoring Devices), Animal Type (Dogs, Cats), Distribution Channel (Veterinary Hospitals and Clinics, Retail Pharmacies, Online Stores), and Region 2024-2032", offers a comprehensive analysis of the industry, which comprises insights on the global pet diabetes care market share. The global market size reached US$ 2.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.7 Billion by 2032, exhibiting a growth rate (CAGR) of 6.77% during 2024-2032.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/pet-diabetes-care-market/requestsample

Factors Affecting the Growth of the Pet Diabetes Care Industry:

  • Rising Prevalence of Obesity in Pets:

Pet obesity is a concerning health issue affecting dogs and cats. Overweight pets are more prone to developing diabetes, which is bolstering the growth of the market. Moreover, pet parents are becoming more aware about the health risks associated with obesity in their pets, thereby they are actively seeking ways to prevent and manage it. Apart from this, they are focusing on maintaining the ideal body weight of their pets through proper nutrition and exercise, which can significantly reduce the risk of diabetes.

  • Advancements in Veterinary Medicine:

Advancements in veterinary medicines, such as diagnostic tools, treatment options, and overall healthcare practices, are propelling the growth of the market. Improved diagnostic techniques allow veterinarians to identify diabetes in pets more accurately and at earlier stages, which is essential for effective management. Additionally, advancements in insulin therapies, glucose monitoring devices, and treatment protocols assist in enhancing the quality of care for diabetic pets, which is strengthening the market growth. Apart from this, the integration of advanced technology into pet glucose monitoring systems enhances the convenience and effectiveness of diabetes care.   

  • Wide Availability of Specialized Products:

The introduction of a wide range of specialized products tailored as per diabetic pets, such as diabetic-friendly pet foods, insulin formulations, glucose monitoring devices, and accessories, is bolstering the growth of the market. These products are carefully designed to meet the unique needs of diabetic pets, ensuring precise dosing, dietary control, and regular monitoring, which is supporting the growth of the market. Besides this, these specialized offerings benefit in enhancing the convenience and effectiveness of diabetes care, making it easier for pet parents and veterinarians to provide optimal support.

Leading Companies Operating in the Global Pet Diabetes Care Industry:

  • ACON Laboratories Inc.
  • Allison Medical Inc.
  • Becton Dickinson and Company
  • Boehringer Ingelheim International GmbH
  • i-SENS Inc.
  • Merck & Co. Inc.
  • Trividia Health Inc. (Sinocare)
  • UltiMed Inc.
  • Zoetis Inc.

Pet Diabetes Care Market Report Segmentation:

By Solution:

  • Treatment
  • Glucose Monitoring Devices

Treatment represented the largest market segment as it involves a wide range of interventions and therapies for managing diabetes in pets.  

By Animal Type:

  • Dogs
  • Cats

Dogs hold the biggest market share due to the rising prevalence of obesity among dogs.     

By Distribution Channel:

  • Veterinary Hospitals and Clinics
  • Retail Pharmacies
  • Online Stores

Veterinary hospitals and clinics exhibit a clear dominance in the market as they offer enhanced services to treat diabetes conditions.       

Regional Insights:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

North America enjoys the leading position in the pet diabetes care market on account of the presence of well-established veterinary healthcare infrastructure.    

Global Pet Diabetes Care Market Trends:

Veterinary professionals and pet healthcare organizations play a vital role in educating pet parents about diabetes prevention and management. They are organizing campaigns and seminars to spread awareness about the importance of regular check-ups, early diagnosis, and proper diabetes care. This encourages pet parents to proactively seek diabetes care services.

The wide availability of pet insurance plans that cover diabetes-related expenses is impelling the market growth. Besides this, financial security encourages pet parents to seek high-quality treatment solutions for their pets.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163